Posted on 9月 7, 20239/7/23
Asset Optimization: Breathe New Life Into Mature Brands with EVERSANA REIGNITE™
Posted on 11月 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on 10月 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net
Posted on 8月 4, 20228/4/22
Macroeconomic Factors Impact Cash Flow for Pharma
Posted on 4月 7, 20224/7/22
Reigniting Revenue for Established Brands
Posted on 4月 7, 20224/7/22
Reignite Established Brands — Actual Use Case
Posted on 4月 29, 20214/29/21
Visualizing EVERSANA’s Omnichannel Activation Model
Posted on 4月 13, 20214/13/21
Expect More From Your Omnichannel Strategy and Investments
Posted on 2月 17, 20212/17/21